BioLineRx (BLRX) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts BLRX Hot Sheet
Join SI Premium – FREE
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.02), $0.04 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kalshi in early talks for IPO - The Information
- Kotak Starts RR Kabel Ltd (RRKABEL:IN) at Sell (4)
- Blue Star Gold closes final tranche of flow-through private placement
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
